News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
473
Sources here
20
Companies here
12
Search results Stored financial headlines

Active search

473 matching headlines

Ticker or company: INITMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Rentokil Initial PLC (RTO.L) Stock Analysis: Exploring a 33% Potential Upside Amidst Market Challenges

Rentokil Initial PLC (RTO.L), a global leader in pest control and hygiene services, shows a potential upside of 33.33% despite current market challenges. While the stock is trading below its moving averages and has a high forward P/E, analysts are optimistic with 12 buy …

RTO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.1% RTO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Will Higher Revenue but Lower EPS in Q2 2026 Change Trinity Capital's (TRIN) Investment Narrative?

Trinity Capital Inc. reported higher revenue of US$87.17 million and net income of US$44.41 million for Q2 2026, but basic and diluted earnings per share (EPS) decreased to US$0.49. This discrepancy, attributed to factors like share issuance, raises questions about how growth translates into …

TRIN main company
Sharemaestro market context Trend signal active 52 weeks +38.4% TRIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Understanding Momentum Shifts in (TRN)

Trinity Industries Inc. (TRN) is showing weak near and mid-term sentiment, challenging a long-term positive outlook, with no clear price positioning signal and elevated downside risk. AI models have generated three distinct trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a …

TRN main company
Sharemaestro market context Trend signal ended 52 weeks +5.2% TRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trinity Capital (TRIN) Receives a Buy from Oppenheimer

Oppenheimer has maintained a Buy rating on Trinity Capital (TRIN) with a price target of $18.00. The company recently reported strong second-quarter earnings, with a revenue of $79.6 million and a net profit of $46.63 million, exceeding previous year's figures. Despite a consensus analyst …

TRIN main company
Sharemaestro market context Trend signal active 52 weeks +38.4% TRIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K bioAffinity Technologies Inc For: 7 August By Investing.com

The article reports that bioAffinity Technologies Inc. filed a Form 8K on August 7th. It briefly mentions the company's stock symbol BIAF and includes general financial market data such as indices, commodities, and shares. The content is primarily a placeholder or boilerplate for financial …

BIAF main company
Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.8% BIAF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trinity Capital Inc (TRNZ) Dividend News Alerts

This page provides dividend news alerts for Trinity Capital Inc (TRNZ). It includes links to TRNZ's stock quote, dividend history, projected 10-year dividend yield, and competitor information. The article also features quick links to various dividend investment tools and related news.

TRIN main company
Sharemaestro market context Trend signal active 52 weeks +38.4% TRIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trinity Biotech PLC (TRIB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Trinity Biotech PLC (TRIB), focusing on future EPS and revenue growth estimates. It includes current stock information, market cap, and a comparison with peer companies in the healthcare equipment sector. The data presented was last updated on …

TRIB main company
Sharemaestro market context Price below Trend Line 52 weeks -75.2% · Next-week setup negative 37.4% TRIB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

bioAffinity Technologies, Inc. Q2 2026: Revenue $1.51M, EPS $(0.64) — 10-Q Summary

bioAffinity Technologies, Inc. (BIAF) reported its Q2 2026 financial results, with revenue increasing by 19% year-over-year to $1.51M. The company narrowed its net loss to $3.37M, and diluted loss per share improved to $(0.64). Key business highlights include significant growth in CyPath® Lung revenue …

BIAF main company
Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.8% BIAF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioAffinity Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

BioAffinity Technologies, Inc. has released its earnings results for the second quarter and six months ending June 30, 2026. For the second quarter, the company saw an increase in sales to USD 1.51 million compared to USD 1.27 million a year ago, while reducing …

BIAF main company
Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.8% BIAF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Press Release: BioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung

BioAffinity Technologies announced its financial results for the second quarter of 2026, highlighting strong commercial growth for its CyPath® Lung diagnostic. The company reported a significant increase in test volumes and revenue compared to the previous year, driven by expanding insurance coverage and successful …

BIAF main company
Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.8% BIAF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

State Street Corporation (NYSE: TRN custodian) discloses 5.2% holding in Trinity

State Street Corporation has reported a beneficial ownership of 5.2% in Trinity Industries, Inc., totaling 4,123,807 shares of common stock. This disclosure was made via a Schedule 13G SEC filing, indicating that State Street and its investment advisory subsidiaries hold shared voting power over …

TRN main company
Sharemaestro market context Trend signal ended 52 weeks +5.2% TRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trinity Biotech PLC (TRIB) Stock News Today

This article provides current stock information for Trinity Biotech PLC (TRIB), showing its recent trading performance with a 6.79% increase. It notes that more news is expected soon regarding earnings, analyst ratings, and key developments. The page also includes financial data like market capitalization.

TRIB main company
Sharemaestro market context Price below Trend Line 52 weeks -75.2% · Next-week setup negative 37.4% TRIB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rentokil Initial plc Stock 12‑Month Price Target Cut to $32.31, Implies 32% Upside

The average 12-month price target for Rentokil Initial plc (RTO) stock has been lowered to $32.31 from $32.50, according to estimates from 18 analysts. This new target suggests a potential upside of approximately 32% from the August 6th closing price. The consensus rating among …

RTO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.1% RTO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q2 2026 Earnings Miss Despite Higher Revenue Might Change The Case For Investing In Trinity Capital (TRIN)

Trinity Capital (TRIN) reported higher Q2 2026 revenue and net income, but missed analyst earnings and revenue estimates, alongside a decline in per-share earnings. This earnings miss, despite higher revenue, combined with a rising share count and funding costs, could influence investor sentiment and …

TRIN main company
Sharemaestro market context Trend signal active 52 weeks +38.4% TRIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

bioAffinity Technologies earnings beat by $1.46, revenue fell short of estimates

bioAffinity Technologies (NASDAQ: BIAF) reported a second-quarter EPS of $-0.640, significantly beating the analyst estimate of $-2.100 by $1.46. However, the company's revenue for the quarter was $1.5M, falling short of the consensus estimate of $1.7M. The stock has experienced a significant decline over …

BIAF main company
Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.8% BIAF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Affinity Bancshares (NASDAQ: AFBI) EVP equity cashed out at $23 per share

Affinity Bancshares' EVP of Lending, Elizabeth Galazka, reported dispositions of common stock and stock options on August 1, 2026, due to a merger. All directly and indirectly held common shares, including those from her spouse, IRAs, and ESOP, were converted into a right to …

AFBI main company
Sharemaestro market context Trend signal active 52 weeks +21.4% · Next-week setup positive 59.2% AFBI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

Affinity Bancshares (AFBI) COO equity gets $23.00 per share in merger

Affinity Bancshares' Chief Operations Officer, Robert Vickers, disposed of his equity holdings in AFBI as part of a merger agreement. His common shares were converted into cash at $23.00 per share, and stock options were converted into cash equal to $23.00 minus their exercise …

AFBI main company
Sharemaestro market context Trend signal active 52 weeks +21.4% · Next-week setup positive 59.2% AFBI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

bioAffinity Technologies reports Q2 2026 revenue $1.51M, net loss $3.37M, cash $2.43M

bioAffinity Technologies reported its Q2 2026 financial results, showing revenue of $1.51 million, an increase from $1.27 million in Q2 2025, and a net loss of $3.37 million, an improvement from $4.06 million in Q2 2025. The company's cash and cash equivalents decreased to …

BIAF main company
Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.8% BIAF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BIAF: Q2 2026 saw 216% CyPath Lung test growth and 19% revenue increase, with improved net loss

BioAffinity Technologies (BIAF) reported significant growth in Q2 2026, with CyPath Lung test volume increasing by 216% and revenue by 19%. This growth was attributed to accelerated physician adoption and expanded clinical trials. Despite increased operating expenses due to commercialization efforts, the company improved …

BIAF main company
Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.8% BIAF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ward and Smith Advises Fidelity Bank in Completed Acquisition of Affinity Bancshares

Ward and Smith, P.A. provided legal counsel to Fidelity Bank in its successful acquisition of Affinity Bancshares, Inc. and its subsidiary, Affinity Bank, N.A. This transaction, which involved Affinity stockholders receiving $23.00 cash per share, expands Fidelity Bank's operations into Georgia, bringing its total …

AFBI main company
Sharemaestro market context Trend signal active 52 weeks +21.4% · Next-week setup positive 59.2% AFBI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

Balefire LLC Reduces Position in Rentokil Initial PLC $RTO

Balefire LLC significantly reduced its stake in Rentokil Initial PLC by 72.5% in the second quarter, selling 64,678 shares and retaining 24,585 shares valued at $703,000. Despite this, analyst sentiment remains a "Moderate Buy" with an average price target of $31.90, contrasting with the …

RTO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.1% RTO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trinity Capital: The Selloff Made This BDC A Better Buy

Despite Trinity Capital (TRIN) delivering a solid Q2, its stock price dropped by 5% following the earnings release, indicating market disapproval. However, the author argues that based on the fundamental results, TRIN deserves bonus points. This article aims to dissect the Q2 report and …

TRIN main company
Sharemaestro market context Trend signal active 52 weeks +38.4% TRIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context